Lv1
60 积分 2023-11-15 加入
FGFR-Altered Urothelial Carcinoma: Resistance Mechanisms and Therapeutic Strategies
3个月前
已完结
A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
4个月前
已完结
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
5个月前
已完结
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
7个月前
已完结
Cereblon modulator CC-885 induces CRBN-dependent ubiquitination and degradation of CDK4 in multiple myeloma
7个月前
已完结
Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
7个月前
已完结
Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
8个月前
已完结
Development and Validation of LC-MS/MS Methods for the Pharmacokinetic Assessment of the PROTACs bavdeglutamide (ARV-110) and vepdegestrant (ARV-471)
8个月前
已完结
Arvinas’s PROTACs pass first safety and PK analysis
8个月前
已完结
Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
8个月前
已完结
皖公网安备34019202002308
